Compare Tata India Pharma & Healthcare Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.35
2.82
NAV
₹36.61
₹349.81
Fund Started
04 Dec 2015
01 Aug 2005
Fund Size
₹1325.19 Cr
₹1143.58 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 30 days.
1 Year
5.14%
9.98%
3 Year
21.75%
25.97%
5 Year
13.21%
13.92%
Equity
99.60%
95.25%
Cash
0.40%
4.74%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.87% |
Divi's Laboratories Ltd. | 5.92% |
Healthcare Global Enterprises Ltd. | 5.45% |
Abbott India Ltd. | 5.37% |
Max Healthcare Institute Ltd. | 5.17% |
Cipla Ltd. | 5.07% |
Rainbow Children's Medicare Ltd. | 4.23% |
Apollo Hospitals Enterprise Ltd. | 4.06% |
Mankind Pharma Ltd. | 3.73% |
Dr. Reddy's Laboratories Ltd. | 3.73% |
Sun Pharmaceutical Industries Ltd. | 9.49% |
Ajanta Pharma Ltd. | 5.84% |
Lupin Ltd. | 4.23% |
Apollo Hospitals Enterprise Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.45% |
Glenmark Pharmaceuticals Ltd. | 3.35% |
Dr. Reddy's Laboratories Ltd. | 3.35% |
Gland Pharma Ltd. | 3.30% |
Fortis Healthcare Ltd. | 3.23% |
Alkem Laboratories Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
04 Dec 2015
01 Aug 2005
